Search by Drug Name or NDC

NDC 65162-0376-18 Ranolazine 500 mg/1 Details

Ranolazine 500 mg/1

Ranolazine is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is RANOLAZINE.

MedlinePlus Drug Summary

Ranolazine is used alone or with other medications to treat chronic angina (ongoing chest pain or pressure that is felt when the heart does not get enough oxygen). Ranolazine is in a class of medications called anti-anginals. The exact way that ranolazine works is not known at this time.

Related Packages: 65162-0376-18
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ranolazine

Product Information

NDC	65162-0376
Product ID	65162-376_2f7b8e70-ed0c-4d1f-ad46-6f29ab86a7fc
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Ranolazine
Proprietary Name Suffix	n/a
Non-Proprietary Name	Ranolazine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	500
Active Ingredient Units	mg/1
Substance Name	RANOLAZINE
Labeler Name	Amneal Pharmaceuticals LLC
Pharmaceutical Class	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA207690
Listing Certified Through	2024-12-31

Package

NDC 65162-0376-18 (65162037618)

Pricing Information	N/A
NDC Package Code	65162-376-18
Billing NDC	65162037618
Package	180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65162-376-18)
Marketing Start Date	2021-03-12
NDC Exclude Flag	N